Status: current, Defined. Date: 31-Aug 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4605831000168116 | Neuvis (THC 2.5:CBD 2.5) (cannabidiol 2.5 mg + delta-9-tetrahydrocannabinol 2.5 mg) capsule, 30 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4605841000168113 | Neuvis (THC 2.5:CBD 2.5) capsule, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neuvis (THC 2.5:CBD 2.5) capsule, 30 | Is a | delta-9-tetrahydrocannabinol 2.5 mg + cannabidiol 2.5 mg capsule, 30 | true | Inferred relationship | Some | ||
| Neuvis (THC 2.5:CBD 2.5) capsule, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Neuvis (THC 2.5:CBD 2.5) capsule, 30 | has TP | Neuvis (THC 2.5:CBD 2.5) | true | Inferred relationship | Some | ||
| Neuvis (THC 2.5:CBD 2.5) capsule, 30 | has TPUU | Neuvis (THC 2.5:CBD 2.5) capsule | true | Inferred relationship | Some | 629348052 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neuvis (THC 2.5:CBD 2.5) capsule, 30, blister pack | Is a | True | Neuvis (THC 2.5:CBD 2.5) capsule, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR